Indo US Bio-TechNSE:INDOUS -0.27%63 ROA % is 5.93% as of Mar. 2026, which is 43% below its 10-year median of 10.46. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹197.21 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 260 Agriculture companies, Indo US Bio-Tech ranks better than 88.08% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Indo US Bio-Tech's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹79 Mil.
Indo US Bio-Tech's average Total Assets over the quarter that ended in Mar. 2026 was ₹1,331 Mil. Therefore, Indo US Bio-Tech's annualized ROA % for the quarter that ended in Mar. 2026 was 5.93%.
The historical rank and industry rank for Indo US Bio-Tech's ROA % or its related term are showing as below:
NSE:INDOUS'
s ROA % Range Over the Past 10 Years
Min: 3.02 Med: 10.46 Max: 17.85
Current: 11.31
During the past 13 years, Indo US Bio-Tech's highest ROA % was 17.85%. The lowest was 3.02%. And the median was 10.46%.
NSE:INDOUS's ROA % is ranked better than 88.08% of 260
companies
in the Agriculture industry
Industry Median: 3.27
vs NSE:INDOUS: 11.31
Indo US Bio-Tech (NSE:INDOUS) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Indo US Bio-Tech ROA % Related Terms
Indo US Bio-Tech ROA % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Indo US Bio-Tech's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech ROA % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's ROA % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Indo US Bio-Tech (NSE:INDOUS) has a ROA % of 5.93% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Indo US Bio-Tech and its competitors. This is 43% below median its historical median of 10.46. Over the past decade, Indo US Bio-Tech's ROA % has ranged from 3.02 to 17.85. According to the industry distribution chart, Indo US Bio-Tech ranks #31 out of 260 companies in the Agriculture industry, placing it in the top 11.9%.
Is Indo US Bio-Tech's ROA % too high?
Indo US Bio-Tech's current ROA % of 5.93% is 43% below median its 10-year median of 10.46. Over the past 10 years, this metric has ranged from a low of 3.02 to a high of 17.85. The Agriculture industry median ROA % is 3.27. Indo US Bio-Tech's value of 5.93% is 81.3% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #31 out of 260 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's ROA % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #31 out of 260 companies for ROA %. This places Indo US Bio-Tech in the top 12% of its industry — outperforming the majority of peers. The industry median ROA % is 3.27. Indo US Bio-Tech's value of 5.93% is 81.3% above this benchmark. Historically, Indo US Bio-Tech's own ROA % has ranged from 3.02 to 17.85 over the past decade. While the company's 10-year median is 10.46 vs. the industry median of 3.27, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for an Agriculture company?
The median ROA % among Agriculture companies is 3.27, based on 260 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current ROA % of 5.93% is 81.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median ROA % is 3.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current ROA % is 5.93%, which is 43% below median its own 10-year median of 10.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹197.21, compared to a current price of ₹88.75 — trading 55% below its estimated fair value. The current ROA % is 5.93%, which is 43% below median its 10-year median of 10.46 and 81.3% above the Agriculture industry median of 3.27. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current ROA % is 5.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.75 is trading 55% below its estimated GF Value™ of ₹197.21.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
ROA %: 5.93% (43% below median its 10-year median of 10.46)
GF Value™: ₹197.21 vs. price of ₹88.75 (55% below fair value)
Industry Position: 81.3% above the Agriculture median (#31 of 260)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
